Package 70377-087-11

Brand: dasatinib

Generic: dasatinib
NDC Package

Package Facts

Identity

Package NDC 70377-087-11
Digits Only 7037708711
Product NDC 70377-087
Product ID 70377-087_6718ab7c-7205-4927-4055-0ce76dfca7ac
Description

30 TABLET, FILM COATED in 1 BOTTLE (70377-087-11)

Marketing

Marketing Status
Marketed Since 2025-03-03
Brand dasatinib
Generic dasatinib
Sample Package No

Linked Drug Pages (1)

Dasatinib ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "6718ab7c-7205-4927-4055-0ce76dfca7ac", "openfda": {"unii": ["RBZ1571X5H"], "rxcui": ["643105", "643107", "643109", "799047", "1045402", "1045406"], "spl_set_id": ["76e1833c-e105-5a3d-0f01-1330d8cc7ae1"], "manufacturer_name": ["Biocon Pharma Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (70377-087-11)", "package_ndc": "70377-087-11", "marketing_start_date": "20250303"}], "brand_name": "Dasatinib", "product_id": "70377-087_6718ab7c-7205-4927-4055-0ce76dfca7ac", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Kinase Inhibitor [EPC]", "Protein Kinase Inhibitors [MoA]"], "product_ndc": "70377-087", "generic_name": "dasatinib", "labeler_name": "Biocon Pharma Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Dasatinib", "active_ingredients": [{"name": "DASATINIB", "strength": "100 mg/1"}], "application_number": "ANDA217217", "marketing_category": "ANDA", "marketing_start_date": "20250303", "listing_expiration_date": "20261231"}